Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis

IMPORTANCE: Antithrombotic treatment in patients with atrial fibrillation (AF) and percutaneous coronary intervention (PCI) presents a balancing act with regard to bleeding and ischemic risks. OBJECTIVES: To evaluate the safety and efficacy of 4 antithrombotic regimens by conducting an up-to-date ne...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Cardiol
Autors principals: Lopes, Renato D., Hong, Hwanhee, Harskamp, Ralf E., Bhatt, Deepak L., Mehran, Roxana, Cannon, Christopher P., Granger, Christopher B., Verheugt, Freek W. A., Li, Jianghao, ten Berg, Jurriën M., Sarafoff, Nikolaus, Vranckx, Pascal, Goette, Andreas, Gibson, C. Michael, Alexander, John H.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7240352/
https://ncbi.nlm.nih.gov/pubmed/32101251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2019.6175
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars